Fertility Outcomes in Leukemia Survivors by Treatment Modality: A Systematic Review and Meta-Analysis
Cancers · 30.07.2026 · 18 (15) · 2455
DOI: 10.3390/cancers18152455 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.07.2026. Verfasst von Judith Altmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology with Center of Oncological Surgery, Charité-Universitätsmedizin Berlin, Augusteburger Platz 1, 13353 Berlin, Germany. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Cancer League, Deutsche José Carreras Leukämie-Stiftung.
Abstract (Originalsprache)
Introduction
Leukemia is the most common childhood malignancy. Treatment requires urgent polychemotherapy and may escalate to hematopoietic stem cell transplantation (HSCT) with or without total body irradiation (TBI). Due to the frequently young age at diagnosis, time limitations and unpredictable course, fertility preservation (FP) is especially challenging and may not be feasible prior to treatment, particularly in females.
Methods
We conducted a systematic review and meta-analysis of fertility outcomes in leukemia survivors using MEDLINE, Embase, and Cochrane databases (search date: 13 June 2024).
Results
Forty-two studies with 2048 patients were included. Overall infertility was 37% (95% CI 23–54%) with substantial heterogeneity. The highest infertility rates were observed after HSCT (68%) and after testicular irradiation (92%) or TBI ≥ 10–12 Gy (66%). Chemotherapy alone was associated with lower infertility (4%). Sex-specific differences were noted, with higher infertility in males following chemotherapy-only regimens (18% vs. 6% in females), while females were more affected after HSCT (70% vs. 59% in males). Subfertility affected about one-fifth of survivors.
Conclusions
While standard chemotherapy is associated with relatively low gonadotoxicity, HSCT and irradiation confer substantial risk. These findings support individualized fertility counseling and long-term reproductive follow-up based on treatment exposure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology with Center of Oncological Surgery, Charité-Universitätsmedizin Berlin, Augusteburger Platz 1, 13353 Berlin, Germany.
- Division of Gynecological Endocrinology and Reproductive Medicine, University Women's Hospital, Inselspital Bern, University of Bern, 3010 Bern, Switzerland.
- Medical Library, University Library Bern, University of Bern, 3012 Bern, Switzerland.
- Department of Oncology, Hepatology and Pneumology, University Cancer Center Leipzig, University Hospital Leipzig, Liebigstraße 22, 04103 Leipzig, Germany.
- Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
ORCID-Profile: Judith Altmann, Nadine Einsiedel, Tanya Karrer, Michael von Wolff
Förderung
- Swiss Cancer League
- Deutsche José Carreras Leukämie-Stiftung
Zitieren
APA
Altmann, J., Einsiedel, N., Pape, J., Weidlinger, S., Karrer, T., von Wolff, M., & Balcerek, M. (2026). Fertility Outcomes in Leukemia Survivors by Treatment Modality: A Systematic Review and Meta-Analysis. Cancers, 18(15), 2455. https://doi.org/10.3390/cancers18152455
Vancouver
Altmann J, Einsiedel N, Pape J, Weidlinger S, Karrer T, von Wolff M, et al. Fertility Outcomes in Leukemia Survivors by Treatment Modality: A Systematic Review and Meta-Analysis. Cancers. 2026;18(15):2455. doi:10.3390/cancers18152455
BibTeX
@article{Altmann2026,
author = {Altmann, Judith and Einsiedel, Nadine and Pape, Janna and Weidlinger, Susanna and Karrer, Tanya and von Wolff, Michael and Balcerek, Magdalena},
title = {Fertility Outcomes in Leukemia Survivors by Treatment Modality: A Systematic Review and Meta-Analysis},
journal = {Cancers},
year = {2026},
volume = {18},
number = {15},
pages = {2455},
doi = {10.3390/cancers18152455}
}
EUVIMED